Afluria Flu Vaccine Shipment Has Begun

Afluria (influenza vaccine) by bioCSL
Afluria (influenza vaccine) by bioCSL

bioCSL Inc. announced that shipping has begun for Afluria (trivalent, inactivated "split virus" influenza vaccine [types A and B]) for the 2014–2015 flu season.

Afluria is an inactivated influenza vaccine indicated for active immunization against influenza caused by virus subtypes A and type B. It is approved for use in patients aged ≥5 years old.

RELATED: Which Flu Vaccine is Right for Your Patient?

The company anticipates delivering about 16.5 million doses of the 2014–2015 formulation with about 75% of doses in thimerosal-free prefilled syringes. Healthcare providers who have ordered Afluria may be able to start administering vaccinations as early as this month.

Afluria is available as 0.5mL single-dose prefilled syringes in 10-count cartons, and 5mL multi-dose vials in 1-count cartons.

For more information call (844) 275-2461 or visit